A novel transduction mechanism mediating dopamine-induced vascular relaxation: Opening of BK(Ca) channels by cyclic AMP-induced stimulation of the cyclic GMP-dependent protein kinase

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 5, 1999, Pages 619-627

  Han, Guichun ^a,b   Kryman, Jonathan P ^a   McMillin, Patricia J P ^a   White, Richard E ^a   Carrier, Gerald O ^c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

BK(Ca) potassium channel; Coronary artery; DA receptor; PKA; PKG

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; IBERIOTOXIN; POTASSIUM; POTASSIUM CHANNEL; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DILATATION; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CYCLIC AMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNEL GATING; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RECEPTORS, DOPAMINE D1; SWINE; VASODILATION;

EID: 0032692345     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199911000-00001     Document Type: Article

References (38)

1. Paterna S, Di Pasquale P, Antona A, et al. Effects of dopamine on isolated failing rat heart. Int J Tissue React 1994;16:243-50.
2. Semeraro C, Marchini F, Ferlenga P, et al. The roles of dopaminergic agonists in congestive heart failure. Clin Exp Hypertens 1997;19:201-15.
3. O'Dowd BF, Seeman P, George SR. Dopamine receptors. In: Peroutka SJ, ed. Handbook of receptors and channels. Boca Raton: CRC Press, 1994:95-123.
4. Sibley DR, Monsma J. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992;13:61-9.
5. Hughes AD, Sever PS. Action of fenoldopam, a selective dopamine (DA1) receptor agonist, on isolated human arteries. Blood Vessels 1989;26:119-27.
6. Kopia GA, Valocik RE. Demonstration of specific dopamine-1 receptor mediated coronary vasodilation in the anesthetized dog. J Pharmacol Exp Ther 1989;248:215-21.
7. Amenta F, Ferrante F, Rossodivita A, Ricci A. Pharmacological characterization and autoradiographic localization of dopamine receptors in human epicardial arteries. J Pharmacol Exp Ther 1992; 263:1447-53.
8. Bolton TB, Beech DJ. Smooth muscle potassium channels: their electrophysiology and function. In: Weston AH, Hamilton TC, eds. Potassium channel modulators. London: Blackwell Scientific Publications, 1992:144-80.
9. + channel current by a mu-type opioid receptor. Mol Pharmacol 1994;46:793-8.
10. Ca channels through a cGMP-dependent mechanism. Circ Res 1995;77:936-42.
11. + currents in human coronary artery vascular smooth muscle cells. Circ Res 1996;78:676-88.
12. Carrier GO, White RE. Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta. J Pharmacol Exp Ther 1985;232:682-7.
13. 1 receptor and vascular endothelium. Blood Vessels 1984;176:288-93.
14. Darkow DJ, Lu L, White RE. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP. Am J Physiol 1997;272:H2765-73.
15. Toro L, Scornik F. Modulation of Ca-activated K channels from coronary smooth muscle. In: Sperelakis N, Kuriyama H, eds. Ion channels of vascular smooth muscle cells and endothelial cells. New York: Elsevier Science Publishers, 1991:111-24.
16. + channels in smooth muscle cells from basilar artery of guinea pig. Pflugers Arch Eur J Physiol 1995;430:984-93.
17. Kelly RA, Smith TW. Drugs used in the treatment of heart failure. In: Braunwald E, ed. Heart disease. Philadelphia: WB Saunders, 1997:485.
18. 2+-ions. Pflugers Arch 1989;414: S183-4.
19. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, White RE. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol 1997;273: H76-84.
20. Lokhandawala MF, Hegde SS. Cardiovascular pharmacology of dopamine receptor agonists. In: Amenta F, ed. Peripheral dopamine receptors. Boca Raton: CRC Press, 1990:63-77.
21. + channel by cyclic AMP in cultured coronary artery smooth muscle cells. Life Sci 1993;53: 1129-35.
22. + channel activity in tracheal myocytes by phosphorylation Nature 1989;431:152-4.
23. Ca channels in airway smooth muscle by a cAMP-dependent and -independent mechanism. J Clin Invest 1994;93:371-9.
24. Ozono R, O'Connell P, Vaughan C, et al. Expression of the subtype 1A dopamine receptor in the rat heart. Hypertension 1996; 27:693-703.
25. s protein mapped with synthetic peptides. Biochim Biophys Acta 1994;1223:261-6.
26. Wang W, Zhao RR, Qin FZ. Comparison of the effects of dopamine1- and dopamine2-receptor agonists on the cAMP generating system in canine coronary and renal arteries. Methods Find Exp Clin Pharmacol 1994;10:691-6.
27. Levitan IB. Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol 1994;56:193-212.
28. Talpain E, Armstrong RA, Coleman RA, Vardey CJ. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol 1995;114: 1459-65.
29. Lincoln TM. Cyclic GMP receptor proteins. In: Lincoln TM, ed. Cyclic GMP: biochemistry, physiology, and pathophysiology. Austin: RG Landes, 1994:57-82.
30. + channels through protein dephosphorylation. Nature 1991;351:570-3.
31. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 1989;264:1146-55.
32. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol 1990;158:C399-407.
33. 2+ desensitization of skinned rat artery. Eur J Pharmacol 1997;323:75-82.
34. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-triphosphate receptor: cyclic GMP-dependent protein kinase mediates cAMP- and cGMP-dependent phosphorylation in the intact rat aorta. J Biol Chem 1996;271:21933-8.
35. Francis SH, Noblett BD, Todd BW, Wells JN, Corbin JD. Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol 1988;34:506-17.
36. Wood JS, Yan X, Mendelow M, Corbin JD, Francis SH, Lawrence DS. Precision substrate targeting of protein kinases: the cGMP-and cAMP-dependent protein kinases. J Biol Chem 1996;271: 174-9.
37. Reinhart PH, Chung S, Martin BL, Brautigan DL, Levitan IB. Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A. J Neurosci 1991; 11:1627-35.
38. 2+ and pH and activated by protein kinase A. Glia 1997;19:311-23.